Immunohistochemical analysis showed that compared with normal tissues, the protein level of CDKN1A was significantly down-regulated in melanoma, while the CDKN2A protein level was significantly up-regulated (Supplementary Figure 5C). This evidence concerns the gene CDKN1A and melanoma.